XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.00 (0.00%)
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
XBiotech price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
XBiotech's price to book ratio was 0.5× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.4× to 1.2×, with a median of 0.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | +0.0 |
| 2025 | Dec 31, 2025 | 0.4× | −0.2 |
| 2024 | Dec 31, 2024 | 0.6× | +0.1 |
| 2023 | Dec 29, 2023 | 0.5× | +0.1 |
| 2022 | Dec 30, 2022 | 0.4× | −0.8 |
| 2021 | Dec 31, 2021 | 1.2× | −0.1 |
| 2020 | Dec 31, 2020 | 1.3× | −10.5 |
| 2019 | Dec 31, 2019 | 11.9× | +8.0 |
| 2018 | Dec 31, 2018 | 3.9× | +1.8 |
| 2017 | Dec 29, 2017 | 2.1× | −2.5 |
| 2016 | Dec 30, 2016 | 4.6× | +1.5 |
| 2015 | Dec 31, 2015 | 3.1× | – |
See a number that looks wrong?